Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Pharmacoeconomics|April 10, 2013
Trabectedin for the treatment of advanced metastatic soft tissue sarcoma: a NICE single technology appraisalRachid Rafia, Emma Simpson, Matt Stevenson, et al.
Journal of Managed Care & Specialty Pharmacy|November 29, 2019
The Effectiveness and Value of Treatments for Spinal Muscular AtrophySteven D Pearson, Praveen Thokala, Matt Stevenson, et al.
Pharmacoeconomics|April 13, 2013
Cabazitaxel for the second-line treatment of metastatic hormone-refractory prostate cancer: a NICE single technology appraisalBen Kearns, Myfanwy Lloyd Jones, Matt Stevenson, et al.
Pharmacoeconomics|September 7, 2018
Trusting the Results of Model-Based Economic Analyses: Is there a Pragmatic Validation Solution?Salah Ghabri, Matt Stevenson, Jörgen Möller, et al.
Pharmacoeconomics|July 3, 2017
Validation of a DICE Simulation Against a Discrete Event Simulation Implemented Entirely in CodeJörgen Möller, Sarah Davis, Matt Stevenson, et al.
Pharmacoeconomics|December 23, 2015
Rivaroxaban for Preventing Atherothrombotic Events in People with Acute Coronary Syndrome and Elevated Cardiac Biomarkers: An Evidence Review Group Perspective of a NICE Single Technology AppraisalAbdullah Pandor, Daniel Pollard, Tim Chico, et al.
BMC Psychiatry|July 8, 2015
The clinical and cost effectiveness of group art therapy for people with non-psychotic mental health disorders: a systematic review and cost-effectiveness analysisLesley Uttley, Matt Stevenson, Alison Scope, et al.
Journal of Bone and Mineral Metabolism|December 21, 2007
The cost-effectiveness of risedronate treatment in Japanese women with osteoporosisHansheng Ding, Nobuo Koinuma, Matt Stevenson, et al.
Pharmacoeconomics|February 20, 2016
Trastuzumab Emtansine for Treating HER2-Positive, Unresectable, Locally Advanced or Metastatic Breast Cancer After Treatment with Trastuzumab and a Taxane: An Evidence Review Group Perspective of a NICE Single Technology AppraisalHazel Squires, Matt Stevenson, Emma Simpson, et al.
The Lancet. Infectious Diseases|December 27, 2019
Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubationLesley Uttley, Christopher Carroll, Ruth Wong, et al.
Pageof 7